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Abstract
The prevalence of diabetes and hyperinsulinemia increases with age, inducing metabolic failure and limiting lifespan.
Calorie restriction (CR) without malnutrition delays the aging process, but its long-term application to humans seems
difficult. Resveratrol (RSV), a dietary polyphenol, appears to be a promising CR mimetic that can be easily administered in
humans. In this work, we hypothesized that both CR and RSV impact insulin sensitivity in a non-human primate compared
to standard-fed control (CTL) animals. Four- to five-year-old male grey mouse lemurs (Microcebus murinus) were assigned to
three dietary groups: a CTL group, a CR group receiving 30% fewer calories than the CTL and a RSV group receiving the CTL
diet supplemented with RSV (200 mg?day
21?kg
21). Insulin sensitivity and glycemia were assessed using an oral glucose
tolerance test (OGTT) and the homeostasis model assessment of insulin resistance (HOMA-IR index) evaluation after 21 or 33
months of chronic treatment. Resting metabolic rate was also measured to assess the potential relationships between this
energy expenditure parameter and insulin sensitivity markers. No differences were found after a 21-month period of
treatment, except for lower glucose levels 30 min after glucose loading in CR animals. After 33 months, CR and RSV
decreased glycemia after the oral glucose loading without decreasing fasting blood insulin. A general effect of treatment
was observed on the HOMA-IR index, with an 81% reduction in CR animals and 53% in RSV animals after 33 months of
treatment compared to CTL. Chronic CR and dietary supplementation with RSV affected insulin sensitivity by improving the
glucose tolerance of animals without disturbing their baseline insulin secretion. These results suggest that both CR and RSV
have beneficial effects on metabolic alterations, although these effects are different in amplitude between the two anti-
aging treatments and potentially rely on different metabolic changes.
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Introduction
Calorie restriction (CR) is the only non-genetic intervention that
extends lifespan and delays the onset or reduces the emergence of
age-associated diseases in short-lived species, such as invertebrates
and rodents [1]. Ample evidence demonstrates the impact of
dietary CR on lifespan extension and on metabolic diseases [2,3]
but the mechanisms by which CR exerts its anti-aging effects are
not yet clear. Although the precise molecular mechanisms for this
action remain controversial, some studies support the central
importance of drastic modifications in energy metabolism [4].
Indeed, the mechanisms triggered by CR play a key role in the
response to reduced energy availability, resulting in the induction
of an altered metabolic state that is thought to promote longevity
[5]. Insulin sensitivity is a relevant marker in evaluating the long-
term health benefits of nutritional interventions, such as CR, as it
increases systemic insulin sensitivity in rodents [6,7,8]. CR also
reduces glycemia and the tissue accumulation of advanced
glycation end products in rats [9]. In agreement with data from
rodents, consistent metabolic changes are observed secondary to a
CR treatment in the non-human primate Macaca mulatta,
suggesting that the group with greater circulating insulin exhibits
a faster age-dependent decline in survival rate [10,11,12]. In one
study, CR monkeys (.18 years old) exhibit less diabetes and
cardiovascular disease risks compared to control animals ([13]).
Moreover, type II diabetes was not diagnosed in CR primates, in
contrast to CTL groups, in which almost 50% presented diabetic
or pre-diabetic states [14]. In human subjects, observations after 6
months of CR are consistent with those in monkeys and rodents in
terms of lower insulin levels, in addition to basal metabolic rate
and body temperature [15]. These data provide evidence that CR
may have beneficial effects in protecting against diabetes or insulin
resistance.
Nevertheless, due to social, economic and medical reasons,
compliance to a CR paradigm seems impractical in humans,
especially in the long term. Thus, recent research has developed
CR mimetics [16,17]. Among these, resveratrol (3,5,40-trihy-
droxy-trans-stilbene, RSV) has received special attention, as this
polyphenol reduces many consequences of a high-calorie diet in
mice and increases their survival by protecting them against
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the pancreatic islets in normal rats [19], and similarly to CR, it
lowers blood insulin in rodents [18,20]. Thus, RSV may play an
important role in energy regulation processes by targeting the
insulin pathway. However, despite the numerous studies in short-
lived species (flies, nematodes, mice and rats) on CR and aging,
only a few have concerned long-lived species, and the effects of CR
and those of a CR mimetic have not been compared in primates.
Thus, the objective of this study was to determine whether long-
term RSV treatment prevents the age-related decrease in insulin
sensitivity similarly to long-term CR in a primate species. This
study occurred within the RESTRIKAL program [21], started in
2008, which aimed to investigate the long-term effects of CR or
dietary RSV supplementation on physiological and behavioral
parameters throughout the aging process of the grey mouse lemur
(Microcebus murinus), which is a unique animal model to investigate
aging (see [22] for review). Indeed longitudinal studies in this
species can be performed on a longer range than those conducted
in rodents, as the mouse lemur presents a median survival time of
5.7 years for males and an average lifespan of 11.060.2 years,
based on data from the Brunoy breeding colony [22], living up to
two-three times longer than mammals of equivalent body mass
[23].
In this study, we chose to use the oral glucose tolerance test
(OGTT) to measure insulin sensitivity. Even though the glucose
clamp technique [24] is widely accepted as the standard reference
for directly determining metabolic insulin sensitivity in humans,
this method requires anesthesia, which is known to influence
glycemia even in a fasting state. Additionally, OGTT reflects the
efficiency with which the organism disposes of glucose after an oral
glucose load. Thus, it provides useful information about glucose
tolerance, and the OGTT data allow for the assessment of one of
the surrogate validated indices of insulin sensitivity, the homeo-
stasis model assessment (HOMA-IR index). In addition, the grey
mouse lemur does not allow for large blood volume sampling
because it has a low circulating blood volume. Thus, OGTT was
the most suitable method to evaluate the glucose tolerance and
insulin resistance of this primate model. Markers of insulin
sensitivity were assessed through OGTT and the HOMA-IR
index in two different groups of mouse lemurs: one group after 21
months of chronic CR or RSV treatment and another group after
33 months of chronic CR or RSV treatment. The resting
metabolic rate (RMR) was also assessed, as it is a relevant
component of daily energy expenditure estimation and a widely
used predictive factor of body mass gain in human studies [25].
RMR has also been associated with metabolic syndrome in
humans [26]. We were therefore interested in evaluating the
relationships between this parameter and markers of insulin
sensitivity.
Materials and Methods
Ethics statement
All experiments were performed in accordance with the
Principles of Laboratory Animal Care (National Institutes of
Health publication 86-23, revised 1985) and the European
Communities Council Directive (86/609/EEC). The research
was conducted under the authorization number 91–305 from the
‘‘Direction De ´partementale des Services Ve ´te ´rinaires de l’Es-
sonne’’ and the Internal Review Board of the UMR 7179. In
accordance with the recommendations of the Weatherall report,
‘‘The use of non-human primates in research’’, special attention
was paid to the welfare of the animals during this work to
minimize nociception [27].
Animals and husbandry
All grey mouse lemurs studied were males that were born in the
laboratory breeding colony of Brunoy (UMR 7179 CNRS/
MNHN, France; European Institutions Agreement # 962773).
These animals were part of the RESTRIKAL study [21]. The
general conditions of captivity were constant. Animals were
exposed to ambient room temperature (24–26uC) and relative
humidity (55%). In captivity, seasonal variations of physiological
and behavioral functions were entrained by alternating between 6
months of a long-day (LD) photoperiod (14:10 light:dark) and 6
months of a short-day photoperiod (SD) (10:14 light:dark), under
artificial light (white light, 250 lux, wavelength peak at 488 nm).
Animals were studied during the LD period, and measurements
were made at least 2 months after the onset of the season, when
their physiological status was stabilized. To minimize social
influences, animals were housed individually in cages
(50640630 cm), visually separated from each other. All tests
were performed during the last 4 hours of the light phase, when
animals begin their daily activity. The body mass of each animal
was measured every week and the day before measurements to
avoid stress from frequent handling. For ethical reasons, special
attention was paid to the body mass evolution of the CR group
because of their leanness during the LD period.
Dietary interventions
Animals were fed fresh fruits and a daily mixture made up of
ginger bread, cereals, milk and eggs [21]. Water was given ad
libitum. Thirty-four animals were used in this study, randomly
distributed into three different dietary groups at the age of 3861
months: an ad libitum CTL group, a group of animals submitted to
CR that were fed the same diet but received 30% less than CTL
and a third group of animals supplemented with RSV that were
fed the same quantity of food as CTL but supplemented with
200 mg of RSV per kilogram body mass per day (Sequoia
Research Products, United Kingdom). This dosage was selected
from the literature from studies in rodents, and was intermediate
between the 5.2 mg/kg.d21 of Baur et al. [28] and the 400 mg/
kg.d21 of Lagouge et al. [29]. To measure the exact quantity of
food ingested by the animals, daily leftovers were measured and
corrected for water evaporation. In this cross-sectional study,
measurements were performed on two cohorts of animals: one
cohort exposed to 21 months of treatment (n CTL=5, n CR=5,
n RSV=6, age: 59.961.2 months) and one cohort exposed to 33
months of treatment (n CTL=5, n CR=5, n RSV=8, age:
71.861.1 months).
Evaluation of fasting glycemia and glycemic response to
OGTT
Glucose metabolism was assessed during the LD period, three
months after the onset of the LD season. On the eve of the oral
glucose tolerance test (OGTT), the food portion (fresh fruit and
mixture) was removed from the cage. Fasting glycemia was
measured using a non-invasive method with a hand-held blood
glucose meter (Accu-Chek ActiveH, Hoffmann-La Roche, Swit-
zerland) at the end of the resting phase of the animal but before
food became available. OGTT was performed using a 1.75 g
glucose.kg
21 body mass glucose challenge, consistent with
previous research in rodents [30]. Animals received the oral
glucose load between 1100 and 1115 am in the form of anhydrous
glucose (Glucose RectapurH, BDH Prolabo, UK) diluted in 0.6 ml
of water, administered per os over 1 min. The hand-held
glucometer required only 5 ml of total blood for each test stick,
which were collected via the saphenous vein, in duplicate. Time
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(Figure S1) in a sub-cohort of animals, with a lower sample size
(CTL n=3; CR n=2; RSV n=3). It showed no peak at 15 min
after the oral load of glucose in the same experimental conditions
as the final study. On the basis of the pilot results and since it is
difficult to collect a high number and volume of blood samples in
the grey mouse lemurs, we decided to focus on the most
informative time points. Thus, blood was sampled at 30, 60 and
120 minutes after the glucose challenge. The first measurement
corresponded to fasting glycemia.
Plasma insulin assays
Fasting blood sampling for insulin assays was performed before
the OGTT and at the same time as the fasting blood sampling for
baseline glycemia. Blood samples were taken via the saphenous
vein, without anesthesia, at the end of the resting phase but before
food became available. Blood samples (100 to 150 mL) were
collected in tubes containing EDTA and represented less than 1%
of the blood volume of each animal. However, we failed to take a
blood sample from two CR animals; thus, only 8 CR animals were
available for insulin assessment. Blood samples were centrifuged at
2000 g at 4uC for 30 min. Before storage of plasma at 280uC, the
samples underwent a second centrifugation at 2000 g at 4uC for
10 min. Plasma insulin was measured in simplicate due to the
minimal plasma volume collected using the Human Insulin assay
method (Elisa technology, Cat. # EZHI-14K).
Insulin resistance index
Basal insulin resistance was estimated by HOMA-IR, which was
calculated using fasting glucose and fasting insulin as an
assessment of basal insulin resistance [31]. Fasting insulin and
glucose collected at the time of the OGTT were used in the
HOMA-IR formula as follows: HOMA-IR=Fasting insulin (mIU/
mL) * Fasting glucose (mmol/L)/22.5 [32].
Resting metabolic rate
Oxygen consumption was measured with a closed-circuit
respirometer one month after the OGTT and the fasting insulin
level assays (i.e., after 22 or 34 months of treatment). For this
nocturnal species, RMR measurements were performed during
their daily resting period, 4–6 h after the beginning of the light
period, to avoid torpor metabolism. Animals were trained to nest
in the respiratory chamber, which consisted of 2.5-L opaque
chamber with a woven floor to absorb any urine. During the
experiment, the respiratory chamber was placed in a cabinet at a
controlled ambient temperature of 25.060.5uC, a value within the
thermo-neutral zone defined for the mouse lemur [33]. After a
20 min habituation phase under constant airflow ventilation
(2 L?min
21) drawn through the respirometry chamber from
bottom to top, the chamber was closed for 40 min. The VO2
consumed by the animal was calculated from the initial and final
concentrations of O2 in the chamber, which were measured on
dried gas using a Servomex 570 A paramagnetic gas analyzer
(accuracy 0.01% O2). The analyzer was routinely calibrated with
N2 and atmospheric air. O2 consumption was expressed as mL
O2?h
21 and was adjusted for the body mass of the animal [34].
Data analysis and statistics
The Shapiro-Wilk goodness-of-fit test was applied to determine
whether the sample data were likely to derive from a normally
distributed population. All data were analyzed to estimate and test
the individual and interactive effects of treatments (diets) and
treatment duration using two-way ANOVA. Bonferroni post-hoc
tests were used to determine the significance of differences
between each pair of the three groups. Two-way ANOVA for
repeated measures with consecutive multiple comparison tests was
used to compare the time courses of glucose during OGTT among
the CTL, CR and RSV animals. Simple linear regressions were
also used to determine the significance levels of correlations among
variables. All analyses were performed with SYSTAT version 12
(SYSTAT Software, Inc., San Jose, California). A level of p,0.05
was set for significance, and all values are expressed as means 6
standard errors of the mean (SEM).
Results
Effects of age and treatments on body mass and OGTT-
related parameters
As shown in Figure 1, body mass varied significantly among the
three groups, as we observed an important effect of treatment
(dF=2/28, F=8.562, p=0.001), while no general effect of age
occurred (dF=1/28, F=0.719, p=0.404). However, body mass
was not different among the three groups after 21 months of
treatment; only the CR animals presented significantly lower body
mass after 33 months of treatment compared to the CTL animals
(p=0.003).
The OGTT results are presented in Figure 2, for each
treatment and by age group. OGTT measurements significantly
varied according to the treatment (dF=2/28, F=6.926,
p=0.004), regardless of the duration of the treatment (dF=1/
28, F=2.418, p=0.131). Additionally, OGTT values varied
within the time course (dF=3/84, F=39.68, p,0.001) according
to the treatment (6/84, F=5.74, p,0.001) and treatment duration
(dF=3/84, F=3.61, p=0.017). After 21 months of treatment, the
CR and RSV animals presented slight decreases in glucose
compared to the CTL animals, but neither was significant.
However, after 33 months of treatment, post-hoc tests revealed
that the CR animals presented lower plasma glucose levels at 30
and 60 minutes after the beginning of the OGTT (p=0.012 and
p=0.041, respectively). The RSV animals presented lower glucose
levels at 30 minutes after glucose loading (p=0.043), while no
significant difference was found 60 minutes after the glucose
loading (p=0.074). Additionally, baseline glucose levels were not
different among the three groups at 21 or 33 months nor were
glucose levels 120 minutes after the glucose loading.
Figure 1. Body mass at oral glucose tolerance test in control
(CTL), calorie restricted (CR) and resveratrol supplemented
(RSV) animals after 21 months of treatment (n CTL=5, n CR=5,
n RSV=6) and after 33 months of treatment (n CTL=5, n CR=5,
n RSV=8). Data are expressed as means6SEM. Statistical significance
(**) p,0.01 when comparing CTL and CR animals.
doi:10.1371/journal.pone.0034289.g001
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as we found a general effect (dF=2/28, F=9.073, p=0.001)
regardless of the duration of the treatment (dF=1/28, F=2.979,
p=0.095). Despite the lack of a significant difference in AUC
between either of the treated groups and the CTL group after 21
months of treatment (CR: p=0.263 and RSV: p=0.543), the AUC
of the CR animals was lower after 33 months (p=0.017), as was the
AUC of the RSV animals (p=0.048) compared to the CTL group.
Effects of age and treatments on fasting plasma insulin,
HOMA-IR and RMR
A nearly significant effect of treatment on fasting insulin was
revealed (dF=2/26, F=3.141, p=0.06), while no significant
effect of age was found (dF=1/26, F=1.722, p=0.201), nor was
a crossed effect found (dF=2/26, F=1.856, p=0.176) (Table 1).
HOMA-IR varied according to the treatment (dF=2/26,
F=3.368, p=0.048), regardless of the duration of the treatment
(dF=1/26, F=1.555, p=0.224). The crossed effect between
treatment and age was not significant (dF=2/26, F=1.167,
p=0.327). HOMA-IR in the CR animals was lower than in CTL
by 70% after 21 months of treatment and by 81% after 33 months
of treatment. In the RSV animals, HOMA-IR was similar to the
HOMA-IR of CTL mouse lemurs after 21 months of treatment
but was attenuated by 53% after 33 months of treatment
compared to the CTL animals (Table 1).
RMR did not vary with treatment across the two ages (dF=2/
23, F=2.522, p=0.111). Similarly, no effect of age was found
(dF=1/23, F=0.184, p=0.678), nor was a crossed effect found
(dF=2/23, F=1.89, p=0.185) (Table 1).
Relationships between insulin sensitivity parameters and
metabolic parameters
We combined the data from both cohorts for the simple linear
regressions (Table 2). Fasting insulin and body mass were highly
related in the CTL animals (r=0.89, p,0.001). However, this
relation was not observed for the CR (r=0.122, p=0.773) or RSV
animals (r=0.122, p=0.679). Similarly, HOMA-IR and body
mass were related in the CTL animals (r=0.943, p,0.001) but
not in the CR (r=0.283, p=0.496) or RSV animals (r=0.077,
p=0.794). In addition, the CTL animals exhibited a strong
positive relation between HOMA-IR and RMR (r=0.847,
p=0.033), which was not the case for the CR (r=0.346,
p=0.401) or RSV animals (r=0.077, p=0.802).
Discussion
This study provides insight into whether the effects of CR or
RSV on insulin and glucose functions can occur in the grey mouse
lemur at early–middle age. Our results indicate that beneficial
effects of CR and RSV appeared after 33 months by decreasing
glycemia after a glucose challenge. Additionally, chronic CR and
RSV treatments led to enhanced insulin sensitivity, as indicated by
the HOMA-IR index values, compared to the CTL group,
whatever the duration of treatment.
Figure 2. Plasma glucose concentrations and area under curves (AUC) during oral glucose tolerance test in control (CTL), calorie
restricted (CR) and resveratrol supplemented (RSV) animals. A: after 21 months of treatment and B: after 33 months of treatment. Data are
expressed as means6SEM. Statistical significance (*) p,0.05 when comparing CTL and CR animals, ($)p ,0.05 when comparing CTL and RSV animals.
doi:10.1371/journal.pone.0034289.g002
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resistance occur in the great majority of elderly, with the states of
glucose intolerance due in part to a decline in peripheral tissue
sensitivity to insulin [35]. To maintain glucose homeostasis, the
compensatory response to a decrease in insulin-stimulated glucose
uptake is an increase in plasma insulin concentration, and several
reports have documented a significant direct relationship between
the magnitude of insulin resistance and the degree of associated
hyper-insulinemia innon-diabetic individuals (see[36] for a review).
Nevertheless, the capacity of insulin to stimulate glucose uptake can
vary substantially among non-obese persons with no apparent
disease [37]. During the OGTT, our results did not reveal an effect
of age on the glycemia response to the glucose challenge, neither on
fasting insulin nor on HOMA-IR. Nevertheless, it is important to
note that the study was conducted on 5- to 6-year-old animals,
corresponding to middle age in this species [22].
In CTL animals, both fasting insulin and HOMA-IR were
strongly positively correlated with body mass. To exclude any
cohort effect, we compared body weights of the two cohorts of
animals after the same time of treatment and found no significant
differences (data not shown). These findings confirm previous
research in humans that showed a positive correlation among
body mass index, plasma insulin and plasma glucose in both
normal and obese populations [38]. Their study revealed that total
body mass may be a good indicator of the need to screen for
metabolic disorders, such as type II diabetes, in adult subjects.
However, in most human studies that measured fasting insulin, the
study samples were not representative of the normal population
because they included a large proportion of overweight subjects
[39,40]. Similarly, in the majority of rodent studies, the animals
were overweight [41], genetically obese [42] or on a high-calorie
diet [43,44], which induce both glucose and insulin metabolism
disorders and disturbances of in vivo insulin action [45]. Therefore,
the correlations identified in the CTL mouse lemurs in this study
support the relationships among body mass gain, insulin resistance
and the decline of gluco-regulatory functions, all of which may
occur even in a normal population without nutritional modifica-
tion. Moreover, the negative correlation between the HOMA-IR
and RMR in the CTL animals supports the hypothesis that
glucose metabolism disorders and pre-diabetic states might be
characterized by a lower energy expenditure, which facilitates
body mass gain. One four-year follow-up study in human subjects
indicated that individuals with metabolic syndrome exhibited a
significantly lower RMR adjusted for fat-free mass compared to
the control group, indicating that a low rate of energy expenditure
is a risk factor for body mass gain and obesity [25].
One of the main objectives of this work was to test whether CR
may improve insulin sensitivity in the mouse lemur. We
demonstrated that chronic CR started at the adult age improved
markers of insulin sensitivity. After 33 months of treatment, CR
induced a decrease in body mass when compared to CTL. Weight
loss produces numerous benefits in altered metabolic states,
including reduced glycemia, reduced fasting insulin and increased
insulin sensitivity [46]. Nevertheless, when human subjects
returned to a normal diet after a 24-h reduction in food energy,
the blood glucose concentration increased, suggesting that the
major underlying factor is the reduction in calorie intake rather
than the body mass loss [47]. In mouse lemurs, CR reduced the
glycemia response to a glucose challenge (OGTT) after 33 months
of treatment, but some studies have revealed even faster CR
effects. In over-fed rodents, a moderate CR for 48 h causes
changes in the liver and skeletal muscle metabolism by lowering
the glucose production rate [48]. Similarly, an acute but short-
term CR without malnutrition has been effective in the care of
type II diabetes by improving insulin-stimulated glucose uptake in
humans [49]. However, the CR mouse lemurs in this study were
not overweight or previously over-fed, suggesting that long-term
CR has benefits in non-diabetic individuals by decreasing the
glycemia threshold after the glucose challenge by inducing
metabolic disturbances that only occur with long-term treatment.
We did not identify any correlations between the markers of
insulin sensitivity and body mass or RMR in CR animals. In obese
Table 1. Sample size, fasting plasma levels of insulin and HOMA-IR obtained during the OGTT after 21 months of treatment or
after 33 months of treatment.
21 months of treatment 33 months of treatment
CTL CR RSV CTL CR RSV
Fasting insulin (mIU/mL) 31.35613.40 n=5 12.7464.09 n=4 38.04615.80 n=6 86.85626.73 n=5 14.4762.89 n=4 35.71614.95 n=8
HOMA-IR 5.7262.44 n=5 1.7260.40 n=4 5.9662.25 n=6 12.8562.89 n=5 2.4660.69 n=4 6.0562.65 n=8
Resting metabolic rate
(mL O2/h/g
20.67)
3.5160.30 n=2 3.4560.15 n=5 3.6160.37 n=6 2.7460.32 n=4 3.5860.81 n=5 4.7560.33 n=7
Data are expressed as means6SEM. Control (CTL), calorie restricted (CR), resveratrol (RSV).
doi:10.1371/journal.pone.0034289.t001
Table 2. Table of simple linear regressions in CTL, CR and RSV animals.
Dependent variables Independent variables CTL group CR group RSV group
HOMA-IR Body mass (g) n=10 r=0.940 *** n=8 r=0.122 NS n=14 r=0.122 NS
Fasting insulin (mIU/mL) Body mass (g) n=10 r=0.943 *** n=8 r=0.283 NS n=14 r=0.077 NS
HOMA-IR RMR (mL O2/h/g-0.67) n=6 r=0.847 * n=8 r=0.346 NS n=13 r=0.077 NS
Sample size for each diet groups and Pearson correlation coefficient r are given for each regression, as dependent and independent variables. Statistical significance was
considered when p,0.05 (*), p,0.001 (***), NS: non significance. Control (CTL), calorie restricted (CR), resveratrol (RSV).
doi:10.1371/journal.pone.0034289.t002
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and insulin sensitivity that is statistically superior to the
correlations between weight loss and fasting glucose, fasting
insulin and HOMA-IR [50]. Similarly, insulin sensitivity can
improve because of weight reduction in obese individuals on very
low-calorie diets [51]. Here, in CR mouse lemurs, the absence of a
relationship among the studied parameters indicates a non-
dependence between the decrease of glucose level after the glucose
challenge and the weight loss. This finding suggests that the
enhancement of insulin sensitivity was not only due to weight loss
but also to metabolic changes that occurred during the chronic
CR. In addition, despite no variation with treatment in RMR, the
lack of a relationship between this parameter and the estimation of
insulin sensitivity indicates that modifications in glucose or
hormonal metabolism were independent of metabolic status in
CR animals. However, in future investigations, we should test the
relationships between the variations in body mass over the
duration of treatment and the glucose or insulin parameters, and
the animals could be returned to a normal diet to assess whether
the body mass loss or the reduction in energy expenditure is
responsible for the improved insulin sensitivity.
The second aim of this study was to investigate whether the
beneficial effects observed in CR animals would be replicated in
RSV animals, as the most recent data from animal studies present
a promising perspective of the potential use of RSV in preventing
and treating metabolic disorders, such as diabetes and obesity [29].
Primarily, we did not observe any difference between the body
masses of the RSV and CTL animals, in contrast to what we
observed between the CR and CTL animals after 33 months of
treatment. This finding agrees with previous results from the one-
year report of the RESTRIKAL study [21]. Meanwhile, RSV was
reported to reduce body mass gain in adult mouse lemurs after one
month of treatment [52] or in rats fed a high-fat diet [53], but its
effects are controversial because such results have not been
replicated in other studies [54]. One reason for these discrepancies
is certainly the short-term treatments that have been used, during
which organisms presented decreased body mass that occurs
because of an increase in total energy expenditure [21]. As shown
by Dal-Pan et al., RSV produced an activation of metabolism
without a loss in body mass, in contrast to CR animals, which
exhibited a reduction in energy expenditure, particularly during
the LD season, when the energy constraints are more important
than in the short-day season. In this study, the body masses of the
RSV mouse lemurs did not differ from the CTL mouse lemurs and
did not correlate with plasma insulin or with HOMA-IR, in
contrast to what we observed for the CTL animals. As shown in
the CR animals, the enhancement of insulin sensitivity markers in
the RSV-treated animals was not related to changes in body mass,
even though, as opposed to the CR animals, they had the same
amount of daily calorie intake as the CTL animals. Indeed, the
RSV animals exhibited lower blood glucose levels during OGTT
after 3 years of treatment. RSV and other wine polyphenols have
been proposed to affect blood glycemia through the inhibition of
glucose absorption in the intestine or of its uptake by peripheral
tissues [55]. In addition, RSV decreases insulin secretion and
delays the onset of insulin resistance, possibly by inhibiting ATP-
and voltage-dependent channels in pancreatic beta-cells [56]. We
did not observe lower fasting insulin levels in the RSV animals,
despite a slight decreasing tendency compared to the CTL mouse
lemurs. Similar findings have been shown in type 2 diabetic
patients, in whom a positive effect on glycemia was clearly
revealed after grape seed extract ingestion, but this did not result
in statistically significant changes in blood insulin levels [55]. Data
from the literature and the results of this study indicate that the
capacity of RSV to induce changes in baseline blood insulin levels
remains controversial. Our inconclusive findings could have been
due to the dose given to the animals (200 mg?day
21?kg
21), as
many publications reveal a dose-dependent activity of this
molecule [20]. We can also suggest that RSV may act on glucose
metabolism by decreasing the glycemia response during an
OGTT, which may be due to a physiological insulin-secretory
response to glucose. However, we only assessed the basal insulin
level, and we cannot draw conclusions about the evolution of
insulin release in response to the glucose challenge. However,
Szkudelski demonstrated that RSV decreases the insulin secretion
of rat pancreatic islets when incubated with different glucose
concentrations, while the baseline level of insulin was unchanged
[19]. Moreover, it was clearly observed that a 50 mg?kg
21 dose of
RSV decreased blood insulin without diminishing blood glucose,
supporting the direct insulin-suppressive action of RSV in vivo and
in vitro [57].
In conclusion, we demonstrated that CR and RSV decreased
glycemia during an OGTT without disturbing the fasting insulin
or fasting glucose levels. The fact that glucose decreased in
response to a glucose challenge without concomitant changes in
fasting insulin levels means that CR and RSV were efficient in
enhancing the insulin sensitivity of our animals. These effects were
revealed after 33 months of chronic treatment, when the animals
were adults; thus, these results are promising and have encouraged
us to investigate the impact of these nutritional interventions in old
mouse lemurs. The two anti-aging treatments had effects of
different amplitudes that potentially rely on different metabolic
changes, which suggests that different pathways are involved in
their respective responses. One of the hypothetically similar
pathways between CR and RSV supplementation involves SIRT1,
which we plan to assess in the context of CR and RSV in future
investigations. The beneficial effect of RSV appears to be
mediated by proteins also involved in CR pathways, such as
AMP kinase and PGC-1a, but the precise mechanisms are still
unclear [29,17]. However, lowering energy intake by CR or by
CR mimetic drugs, such as RSV, protects organisms against
diseases and metabolic dysfunctions, in part by hormesis
mechanisms that improve cellular stress resistance [58]. Therefore,
the possibility of following numerous physiological parameters
longitudinally under controlled conditions offers potential value in
the context of clarifying the characteristics and kinetics of the
effects of CR and RSV on insulin sensitivity, especially because of
their potential recommendations for diabetes prevention and care.
Supporting Information
Figure S1 Results of the pilot study. (See the Materials &
Methods section in the manuscript.) Plasma glucose concentra-
tions during oral glucose tolerance test in control (CTL; n=3),
calorie restricted (CR, n=2) and resveratrol supplemented (RSV,
n=3) animals, after 21 months of treatment. There was no
difference between the point at 15 minutes and the point at
30 minutes when considering each group (CTL 15 min vs 30 min,
dF=2; t=0.051, p=0.964; CR 15 min vs 30 min, dF=1,
t=21.687, p=0.341; RSV 15 min vs 30 min, dF=2,
t=20.679, p=0.567) Data are expressed as means6SEM.
(TIF)
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